Correlation Between AP Public and Mega Lifesciences

Can any of the company-specific risk be diversified away by investing in both AP Public and Mega Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AP Public and Mega Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AP Public and Mega Lifesciences Public, you can compare the effects of market volatilities on AP Public and Mega Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AP Public with a short position of Mega Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of AP Public and Mega Lifesciences.

Diversification Opportunities for AP Public and Mega Lifesciences

0.8

Correlation Coefficient

AP Public  Mega Lifesciences

Very poor diversification

The 3 months correlation between AP Public and Mega is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding AP Public and Mega Lifesciences Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mega Lifesciences Public and AP Public is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AP Public are associated (or correlated) with Mega Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mega Lifesciences Public has no effect on the direction of AP Public i.e., AP Public and Mega Lifesciences go up and down completely randomly.

Pair Corralation between AP Public and Mega Lifesciences

Assuming the 90 days horizon AP Public is expected to generate 1.04 times more return on investment than Mega Lifesciences. However, AP Public is 1.04 times more volatile than Mega Lifesciences Public. It trades about 0.03 of its potential returns per unit of risk. Mega Lifesciences Public is currently generating about -0.06 per unit of risk. If you would invest  840.00  in AP Public on September 3, 2024 and sell it today you would earn a total of  25.00  from holding AP Public or generate 2.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

AP Public  vs.  Mega Lifesciences Public

AP Public

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in AP Public are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent fundamental drivers, AP Public is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Mega Lifesciences Public

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mega Lifesciences Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with AP Public and Mega Lifesciences

The main advantage of trading using opposite AP Public and Mega Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AP Public position performs unexpectedly, Mega Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mega Lifesciences will offset losses from the drop in Mega Lifesciences' long position.

The idea behind AP Public and Mega Lifesciences Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.